v3.21.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows from Operating Activities    
Net loss $ (2,378,157) $ (5,086,264)
Adjustments to reconcile net loss to net cash and cash equivalents from operating activities:    
Depreciation and amortization 219,438 160,974
Stock-based compensation expense 389,085 212,413
Amortization of debt costs 182,900
Interest expense on notes payable converted to common stock 3,430,931
Changes in operating assets and liabilities which (used) provided cash:    
Accounts receivable 28,195 (210,670)
Prepaid expenses and other assets 125,999 76,705
Accounts payable 92,651 273,946
Accrued compensation 210,820 250,826
Deferred revenue 76,114 462,061
Accrued and other liabilities 26,483 (66,712)
Net cash and cash equivalents used in operating activities (1,209,372) (312,890)
Cash Flows from Investing Activities    
Purchase of property and equipment (5,747) (19,343)
Investment in capitalized software (267,400) (202,706)
Net cash and cash equivalents used in investing activities (273,147) (222,049)
Cash Flows from Financing Activities – Issuance of common stock – net of issuance costs 1,360,000 12,796,230
Net Increase in Cash and Cash Equivalents (122,519) 12,261,291
Cash and Cash Equivalents - Beginning of period 10,713,091 4,093,874
Cash and Cash Equivalents - End of period 10,590,572 16,355,165
Significant Noncash Transactions:    
Acquisition of capitalized software included in accounts payable and accrued liabilities 72,853 152,535
Conversion of convertible notes payable, including accrued interest of $73,315, into 1,127,872 shares of common stock $ 2,255,745

Source